PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Biohaven Pharma (BHVN) CEO Buys Another $400K in Stock
November 1, 2022 8:19 AM EDTBiohaven Pharma (NYSE: BHVN) CEO, Vlad Coric, bought 25,800 shares on 10/31/22 at $15.968.
The value of the purchase was $411,995.
Yesterday, Coric disclosed the purchase of $2.1 million in stock.
... MorePfizer (PFE) Tops Q3 EPS by 34, Beats on Revenue; Offers FY Guidance
November 1, 2022 6:47 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $1.78, $0.34 better than the analyst estimate of $1.44. Revenue for the quarter came in at $22.6 billion versus the consensus estimate of $21.33 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.30-$6.45, versus the consensus of $6.38. Pfizer sees... More
